MarketPeel
Insider Trading Intelligence
Pricing
…
RC

Ryan Cohlhepp

BCAX
PRESIDENT AND COO · BICARA THERAPEUTICS INC. · CIK 0002034665
FILING MIX · LIFETIME27%/73%
BUYS
12
SELLS
33
TOTAL VALUE
$3.31M
COMPANIES
1
ACTIVE SINCE
Oct 2025
HOLDINGS NOW
191,641
AVG SELL PX
$18.86
TRADE KIND
SHOWING 45 / 45
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
20 backtested trades · 8 horizons · 52 pending
Forward-return performance of every backtestable P/S trade by Ryan Cohlhepp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d20+55.00%+0.10%+0.05%+0.06%-0.82%—
14d20+65.00%-3.78%+0.03%-3.81%-6.43%—
30d20+60.00%-4.28%+0.52%-4.80%-7.66%—
60d20+40.00%+2.60%+3.18%-0.57%-3.52%—
90d20(2 pending)+44.44%+6.39%+3.52%-1.75%-11.11%—
180d20(10 pending)+0.00%+15.32%+4.17%+11.14%+14.56%—
1y20(20 pending)——————
2y20(20 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BCAX · 191,641 shares · as of May 15, 2026
075,000150,000225,000300,0002026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2026
2026
FLOW · 12 buys / 33 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
8,000$3.79$30.3K204,141May 15, 2026May 18, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
8,000——101,334May 15, 2026May 18, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
8,000$20.29$162.3K196,141May 15, 2026May 18, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,500$20.29$91.3K191,641May 15, 2026May 18, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
8,000$23.01$184.1K200,641Apr 15, 2026Apr 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
8,000——109,334Apr 15, 2026Apr 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
8,000$3.79$30.3K208,641Apr 15, 2026Apr 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,500$23.01$103.5K196,141Apr 15, 2026Apr 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
8,000——117,334Mar 16, 2026Mar 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
8,000$3.79$30.3K213,141Mar 16, 2026Mar 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
8,000$19.66$157.3K205,141Mar 16, 2026Mar 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,500$19.66$88.5K200,641Mar 16, 2026Mar 17, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
12,892——125,334Mar 3, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,500$18.16$81.7K205,141Mar 3, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
12,892$18.16$234.2K209,641Mar 3, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
12,892$3.79$48.9K222,533Mar 3, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
523$18.04$9.4K209,641Feb 25, 2026Feb 27, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
3,108$18.04$56.1K210,164Feb 25, 2026Feb 27, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
3,108$3.79$11.8K213,272Feb 25, 2026Feb 27, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
3,108——138,226Feb 25, 2026Feb 27, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
300,000——300,000Feb 2, 2026Feb 4, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
3,828$18.10$69.3K210,164Jan 22, 2026Jan 26, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
149$18.02$2.7K213,992Jan 15, 2026Jan 20, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
25,000$4.44$110.9K214,141Dec 26, 2025Dec 29, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
25,000——39,909Dec 26, 2025Dec 29, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
8,000$18.68$149.5K193,641Dec 15, 2025Dec 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
8,000$3.79$30.3K201,641Dec 15, 2025Dec 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,500$18.68$84.1K189,141Dec 15, 2025Dec 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
8,000——141,334Dec 15, 2025Dec 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,500$18.05$81.2K193,641Nov 21, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
8,000$3.79$30.3K206,141Nov 21, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
8,000——149,334Nov 21, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
8,000$18.05$144.4K198,141Nov 21, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
8,000$18.16$145.2K202,641Oct 15, 2025Oct 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
8,000$3.79$30.3K210,641Oct 15, 2025Oct 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
8,000——157,334Oct 15, 2025Oct 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,500$18.16$81.7K198,141Oct 15, 2025Oct 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
2,900$18.06$52.4K202,641Oct 7, 2025Oct 8, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
8,000$18.06$144.5K205,541Oct 7, 2025Oct 8, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
8,000$3.79$30.3K213,541Oct 7, 2025Oct 8, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
8,000——165,334Oct 7, 2025Oct 8, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
President and COO
24,000$3.79$91.0K245,141Oct 6, 2025Oct 8, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
24,000$18.06$433.3K221,141Oct 6, 2025Oct 8, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
15,600$18.06$281.7K205,541Oct 6, 2025Oct 8, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
President and COO
24,000——173,334Oct 6, 2025Oct 8, 2025 ↗View →
Other insiders · BCAX
Loading peer insiders…
About this filer
CIK 0002034665
ROLE
President and COO
PRIMARY
BCAX
COMPANIES
1
ACTIVE SINCE
Oct 2025
MARKETPEEL · /INSIDER/0002034665DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback